Wiki-CORONA

Search Results for: Pulmonary

5304 interactions found:

Sort by: Relevance Number of Pathways Number of Drugs Number of Diseases
Symbols Name 1 Name 2
Pathways 1
Pathways 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
ALDOA and SUMO4 aldolase, fructose-bisphosphate A small ubiquitin like modifier 4
  • Platelet degranulation
  • Neutrophil degranulation
  • Glycolysis
  • Gluconeogenesis
  • Zinc
  • 1,6-Fructose Diphosphate (Linear Form)
  • Dihydroxyacetone phosphate
  • 1,6-DI-O-PHOSPHONO-D-MANNITOL
  • N-(4-CHLOROPHENYL)-3-(PHOSPHONOOXY)NAPHTHALENE-2-CARBOXAMIDE
ALDOA and BCAT2 aldolase, fructose-bisphosphate A branched chain amino acid transaminase 2
  • Platelet degranulation
  • Neutrophil degranulation
  • Glycolysis
  • Gluconeogenesis
  • Branched-chain amino acid catabolism
  • Zinc
  • 1,6-Fructose Diphosphate (Linear Form)
  • Dihydroxyacetone phosphate
  • 1,6-DI-O-PHOSPHONO-D-MANNITOL
  • N-(4-CHLOROPHENYL)-3-(PHOSPHONOOXY)NAPHTHALENE-2-CARBOXAMIDE
  • Pyridoxal Phosphate
  • Glutamic Acid
  • L-Leucine
  • L-Isoleucine
  • Pyridoxamine-5'-Phosphate
  • N-[O-Phosphono-Pyridoxyl]-Isoleucine
  • Alpha-ketoisovalerate
ALDOA and SRPK2 aldolase, fructose-bisphosphate A SRSF protein kinase 2
  • Platelet degranulation
  • Neutrophil degranulation
  • Glycolysis
  • Gluconeogenesis
  • Zinc
  • 1,6-Fructose Diphosphate (Linear Form)
  • Dihydroxyacetone phosphate
  • 1,6-DI-O-PHOSPHONO-D-MANNITOL
  • N-(4-CHLOROPHENYL)-3-(PHOSPHONOOXY)NAPHTHALENE-2-CARBOXAMIDE
  • Adenine
  • Purvalanol
  • Phosphoaminophosphonic Acid-Adenylate Ester
ALDOA and FANCA aldolase, fructose-bisphosphate A FA complementation group A
  • Platelet degranulation
  • Neutrophil degranulation
  • Glycolysis
  • Gluconeogenesis
  • Fanconi Anemia Pathway
  • Zinc
  • 1,6-Fructose Diphosphate (Linear Form)
  • Dihydroxyacetone phosphate
  • 1,6-DI-O-PHOSPHONO-D-MANNITOL
  • N-(4-CHLOROPHENYL)-3-(PHOSPHONOOXY)NAPHTHALENE-2-CARBOXAMIDE
  • Fanconi anemia
ALDOA and XRN1 aldolase, fructose-bisphosphate A 5'-3' exoribonuclease 1
  • Platelet degranulation
  • Neutrophil degranulation
  • Glycolysis
  • Gluconeogenesis
  • mRNA decay by 5' to 3' exoribonuclease
  • Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA
  • Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA
  • Zinc
  • 1,6-Fructose Diphosphate (Linear Form)
  • Dihydroxyacetone phosphate
  • 1,6-DI-O-PHOSPHONO-D-MANNITOL
  • N-(4-CHLOROPHENYL)-3-(PHOSPHONOOXY)NAPHTHALENE-2-CARBOXAMIDE
ALDOA and TRIM63 aldolase, fructose-bisphosphate A tripartite motif containing 63
  • Platelet degranulation
  • Neutrophil degranulation
  • Glycolysis
  • Gluconeogenesis
  • FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes
  • Antigen processing: Ubiquitination & Proteasome degradation
  • Zinc
  • 1,6-Fructose Diphosphate (Linear Form)
  • Dihydroxyacetone phosphate
  • 1,6-DI-O-PHOSPHONO-D-MANNITOL
  • N-(4-CHLOROPHENYL)-3-(PHOSPHONOOXY)NAPHTHALENE-2-CARBOXAMIDE
ALDOA and PLD2 aldolase, fructose-bisphosphate A phospholipase D2
  • Platelet degranulation
  • Neutrophil degranulation
  • Glycolysis
  • Gluconeogenesis
  • Synthesis of PG
  • Synthesis of PA
  • Role of phospholipids in phagocytosis
  • Zinc
  • 1,6-Fructose Diphosphate (Linear Form)
  • Dihydroxyacetone phosphate
  • 1,6-DI-O-PHOSPHONO-D-MANNITOL
  • N-(4-CHLOROPHENYL)-3-(PHOSPHONOOXY)NAPHTHALENE-2-CARBOXAMIDE
  • Choline
ALDOA and DYNLL1 aldolase, fructose-bisphosphate A dynein light chain LC8-type 1
  • Platelet degranulation
  • Neutrophil degranulation
  • Glycolysis
  • Gluconeogenesis
  • Activation of BIM and translocation to mitochondria
  • Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal
  • Macroautophagy
  • MHC class II antigen presentation
  • Separation of Sister Chromatids
  • Resolution of Sister Chromatid Cohesion
  • Regulation of PLK1 Activity at G2/M Transition
  • HSP90 chaperone cycle for steroid hormone receptors (SHR)
  • Loss of Nlp from mitotic centrosomes
  • Recruitment of mitotic centrosome proteins and complexes
  • Loss of proteins required for interphase microtubule organization from the centrosome
  • Recruitment of NuMA to mitotic centrosomes
  • Anchoring of the basal body to the plasma membrane
  • Intraflagellar transport
  • RHO GTPases Activate Formins
  • Neutrophil degranulation
  • COPI-mediated anterograde transport
  • COPI-independent Golgi-to-ER retrograde traffic
  • Mitotic Prometaphase
  • AURKA Activation by TPX2
  • HCMV Early Events
  • Aggrephagy
  • Aggrephagy
  • EML4 and NUDC in mitotic spindle formation
  • Zinc
  • 1,6-Fructose Diphosphate (Linear Form)
  • Dihydroxyacetone phosphate
  • 1,6-DI-O-PHOSPHONO-D-MANNITOL
  • N-(4-CHLOROPHENYL)-3-(PHOSPHONOOXY)NAPHTHALENE-2-CARBOXAMIDE
ALDOA and ALDOB aldolase, fructose-bisphosphate A aldolase, fructose-bisphosphate B
  • Platelet degranulation
  • Neutrophil degranulation
  • Glycolysis
  • Gluconeogenesis
  • Hereditary fructose intolerance
  • Glycolysis
  • Gluconeogenesis
  • Fructose catabolism
  • Zinc
  • 1,6-Fructose Diphosphate (Linear Form)
  • Dihydroxyacetone phosphate
  • 1,6-DI-O-PHOSPHONO-D-MANNITOL
  • N-(4-CHLOROPHENYL)-3-(PHOSPHONOOXY)NAPHTHALENE-2-CARBOXAMIDE
  • 1,6-Fructose Diphosphate (Linear Form)
  • 3-Phosphoglycerol
  • Dihydroxyacetone phosphate
  • Hereditary fructose intolerance; Fructosemia
ALDOA and CACNA1A aldolase, fructose-bisphosphate A calcium voltage-gated channel subunit alpha1 A
  • Platelet degranulation
  • Neutrophil degranulation
  • Glycolysis
  • Gluconeogenesis
  • Presynaptic depolarization and calcium channel opening
  • Regulation of insulin secretion
  • Zinc
  • 1,6-Fructose Diphosphate (Linear Form)
  • Dihydroxyacetone phosphate
  • 1,6-DI-O-PHOSPHONO-D-MANNITOL
  • N-(4-CHLOROPHENYL)-3-(PHOSPHONOOXY)NAPHTHALENE-2-CARBOXAMIDE
  • Pregabalin
  • Spironolactone
  • Verapamil
  • Loperamide
  • Bepridil
  • Episodic ataxias
  • Familial or sporadic hemiplegic migraine
  • Spinocerebellar ataxia (SCA); Machado-Joseph disease (SCA3)
ALDOA and HSPB2 aldolase, fructose-bisphosphate A heat shock protein family B (small) member 2
  • Platelet degranulation
  • Neutrophil degranulation
  • Glycolysis
  • Gluconeogenesis
  • Zinc
  • 1,6-Fructose Diphosphate (Linear Form)
  • Dihydroxyacetone phosphate
  • 1,6-DI-O-PHOSPHONO-D-MANNITOL
  • N-(4-CHLOROPHENYL)-3-(PHOSPHONOOXY)NAPHTHALENE-2-CARBOXAMIDE
ALDOA and TUBB aldolase, fructose-bisphosphate A tubulin beta class I
  • Platelet degranulation
  • Neutrophil degranulation
  • Glycolysis
  • Gluconeogenesis
  • Regulation of PLK1 Activity at G2/M Transition
  • Loss of Nlp from mitotic centrosomes
  • Recruitment of mitotic centrosome proteins and complexes
  • Loss of proteins required for interphase microtubule organization from the centrosome
  • Recruitment of NuMA to mitotic centrosomes
  • Anchoring of the basal body to the plasma membrane
  • Neutrophil degranulation
  • AURKA Activation by TPX2
  • Zinc
  • 1,6-Fructose Diphosphate (Linear Form)
  • Dihydroxyacetone phosphate
  • 1,6-DI-O-PHOSPHONO-D-MANNITOL
  • N-(4-CHLOROPHENYL)-3-(PHOSPHONOOXY)NAPHTHALENE-2-CARBOXAMIDE
  • Vinorelbine
  • Vincristine
  • Vinblastine
  • Podofilox
  • Colchicine
  • Epothilone D
  • Patupilone
  • CYT997
  • CA4P
  • ZEN-012
  • Copper
  • Depatuxizumab mafodotin
  • Milataxel
ALDOA and TGM2 aldolase, fructose-bisphosphate A transglutaminase 2
  • Platelet degranulation
  • Neutrophil degranulation
  • Glycolysis
  • Gluconeogenesis
  • Zinc
  • 1,6-Fructose Diphosphate (Linear Form)
  • Dihydroxyacetone phosphate
  • 1,6-DI-O-PHOSPHONO-D-MANNITOL
  • N-(4-CHLOROPHENYL)-3-(PHOSPHONOOXY)NAPHTHALENE-2-CARBOXAMIDE
  • Guanosine-5'-Diphosphate
ALDOA and TERF1 aldolase, fructose-bisphosphate A telomeric repeat binding factor 1
  • Platelet degranulation
  • Neutrophil degranulation
  • Glycolysis
  • Gluconeogenesis
  • Recognition and association of DNA glycosylase with site containing an affected pyrimidine
  • Cleavage of the damaged pyrimidine
  • Recognition and association of DNA glycosylase with site containing an affected purine
  • Recognition and association of DNA glycosylase with site containing an affected purine
  • Cleavage of the damaged purine
  • Cleavage of the damaged purine
  • Meiotic synapsis
  • Packaging Of Telomere Ends
  • Telomere Extension By Telomerase
  • DNA Damage/Telomere Stress Induced Senescence
  • Zinc
  • 1,6-Fructose Diphosphate (Linear Form)
  • Dihydroxyacetone phosphate
  • 1,6-DI-O-PHOSPHONO-D-MANNITOL
  • N-(4-CHLOROPHENYL)-3-(PHOSPHONOOXY)NAPHTHALENE-2-CARBOXAMIDE
ALDOA and IFNA4 aldolase, fructose-bisphosphate A interferon alpha 4
  • Platelet degranulation
  • Neutrophil degranulation
  • Glycolysis
  • Gluconeogenesis
  • Interferon alpha/beta signaling
  • Regulation of IFNA signaling
  • Regulation of IFNA signaling
  • TRAF6 mediated IRF7 activation
  • Factors involved in megakaryocyte development and platelet production
  • Zinc
  • 1,6-Fructose Diphosphate (Linear Form)
  • Dihydroxyacetone phosphate
  • 1,6-DI-O-PHOSPHONO-D-MANNITOL
  • N-(4-CHLOROPHENYL)-3-(PHOSPHONOOXY)NAPHTHALENE-2-CARBOXAMIDE
ALDOA and EGFR aldolase, fructose-bisphosphate A epidermal growth factor receptor
  • Platelet degranulation
  • Neutrophil degranulation
  • Glycolysis
  • Gluconeogenesis
  • Signaling by ERBB2
  • Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
  • Signaling by ERBB4
  • SHC1 events in ERBB2 signaling
  • SHC1 events in ERBB2 signaling
  • PLCG1 events in ERBB2 signaling
  • PIP3 activates AKT signaling
  • Signaling by EGFR
  • GRB2 events in EGFR signaling
  • GAB1 signalosome
  • SHC1 events in EGFR signaling
  • EGFR downregulation
  • GRB2 events in ERBB2 signaling
  • PI3K events in ERBB2 signaling
  • EGFR interacts with phospholipase C-gamma
  • EGFR Transactivation by Gastrin
  • Constitutive Signaling by Aberrant PI3K in Cancer
  • Signal transduction by L1
  • Constitutive Signaling by EGFRvIII
  • Inhibition of Signaling by Overexpressed EGFR
  • RAF/MAP kinase cascade
  • ERBB2 Regulates Cell Motility
  • PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
  • ERBB2 Activates PTK6 Signaling
  • Cargo recognition for clathrin-mediated endocytosis
  • Clathrin-mediated endocytosis
  • PTK6 promotes HIF1A stabilization
  • Downregulation of ERBB2 signaling
  • TFAP2 (AP-2) family regulates transcription of growth factors and their receptors
  • Extra-nuclear estrogen signaling
  • NOTCH3 Activation and Transmission of Signal to the Nucleus
  • HCMV Early Events
  • Estrogen-dependent nuclear events downstream of ESR-membrane signaling
  • Signaling by ERBB2 KD Mutants
  • Signaling by ERBB2 ECD mutants
  • Signaling by ERBB2 TMD/JMD mutants
  • Zinc
  • 1,6-Fructose Diphosphate (Linear Form)
  • Dihydroxyacetone phosphate
  • 1,6-DI-O-PHOSPHONO-D-MANNITOL
  • N-(4-CHLOROPHENYL)-3-(PHOSPHONOOXY)NAPHTHALENE-2-CARBOXAMIDE
  • Cetuximab
  • Trastuzumab
  • Lidocaine
  • Gefitinib
  • Erlotinib
  • Lapatinib
  • Panitumumab
  • Alvocidib
  • IGN311
  • Matuzumab
  • Vandetanib
  • Rindopepimut
  • Canertinib
  • Pelitinib
  • Varlitinib
  • S-{3-[(4-ANILINOQUINAZOLIN-6-YL)AMINO]-3-OXOPROPYL}-L-CYSTEINE
  • N-[4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL]-ACRYLAMIDE
  • Afatinib
  • Osimertinib
  • Necitumumab
  • Depatuxizumab mafodotin
  • Icotinib
  • Neratinib
  • Zalutumumab
  • Brigatinib
  • Olmutinib
  • Choriocarcinoma
  • Gastric cancer
  • Bladder cancer
  • Oral cancer
  • Glioma
  • Laryngeal cancer
  • Cervical cancer
  • Esophageal cancer
ALDOA and PIAS4 aldolase, fructose-bisphosphate A protein inhibitor of activated STAT 4
  • Platelet degranulation
  • Neutrophil degranulation
  • Glycolysis
  • Gluconeogenesis
  • Vitamin D (calciferol) metabolism
  • SUMOylation of DNA damage response and repair proteins
  • SUMOylation of transcription factors
  • SUMOylation of ubiquitinylation proteins
  • SUMOylation of transcription cofactors
  • SUMOylation of SUMOylation proteins
  • SUMOylation of intracellular receptors
  • SUMOylation of intracellular receptors
  • SUMOylation of DNA replication proteins
  • SUMOylation of immune response proteins
  • Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks
  • Nonhomologous End-Joining (NHEJ)
  • Processing of DNA double-strand break ends
  • G2/M DNA damage checkpoint
  • Zinc
  • 1,6-Fructose Diphosphate (Linear Form)
  • Dihydroxyacetone phosphate
  • 1,6-DI-O-PHOSPHONO-D-MANNITOL
  • N-(4-CHLOROPHENYL)-3-(PHOSPHONOOXY)NAPHTHALENE-2-CARBOXAMIDE
ALDOA and MLH1 aldolase, fructose-bisphosphate A mutL homolog 1
  • Platelet degranulation
  • Neutrophil degranulation
  • Glycolysis
  • Gluconeogenesis
  • Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)
  • Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)
  • Defective Mismatch Repair Associated With MLH1
  • Defective Mismatch Repair Associated With PMS2
  • TP53 Regulates Transcription of DNA Repair Genes
  • Meiotic recombination
  • Zinc
  • 1,6-Fructose Diphosphate (Linear Form)
  • Dihydroxyacetone phosphate
  • 1,6-DI-O-PHOSPHONO-D-MANNITOL
  • N-(4-CHLOROPHENYL)-3-(PHOSPHONOOXY)NAPHTHALENE-2-CARBOXAMIDE
  • Colorectal cancer
  • Mismatch repair deficiency, including: Hereditary non-polyposis colorectal cancer (HNPCC); Lynch syndrome; Muir-Torre syndrome; Turcot syndrome
  • Endometrial Cancer
  • Ovarian cancer
ALDOA and HSD17B10 aldolase, fructose-bisphosphate A hydroxysteroid 17-beta dehydrogenase 10
  • Platelet degranulation
  • Neutrophil degranulation
  • Glycolysis
  • Gluconeogenesis
  • tRNA processing in the mitochondrion
  • tRNA modification in the mitochondrion
  • Branched-chain amino acid catabolism
  • rRNA processing in the mitochondrion
  • Zinc
  • 1,6-Fructose Diphosphate (Linear Form)
  • Dihydroxyacetone phosphate
  • 1,6-DI-O-PHOSPHONO-D-MANNITOL
  • N-(4-CHLOROPHENYL)-3-(PHOSPHONOOXY)NAPHTHALENE-2-CARBOXAMIDE
  • NADH
  • 1-Azepan-1-Yl-2-Phenyl-2-(4-Thioxo-1,4-Dihydro-Pyrazolo[3,4-D]Pyrimidin-5-Yl)Ethanone Adduct
  • 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency; HSD10 deficiency
  • Non-syndromic X-linked mental retardation
  • Syndromic X-linked mental retardation, including: Turner type (MRXST); Siderius type (MRXSSD) ; Cabezas type (MRXC); Raymond type (MRXSR); Type10 (MRXS10); Type14 (MRXS14); Mental retardation with isolated growth hormone deficiency (MRGH)
ALDOA and GALNT6 aldolase, fructose-bisphosphate A polypeptide N-acetylgalactosaminyltransferase 6
  • Platelet degranulation
  • Neutrophil degranulation
  • Glycolysis
  • Gluconeogenesis
  • O-linked glycosylation of mucins
  • Zinc
  • 1,6-Fructose Diphosphate (Linear Form)
  • Dihydroxyacetone phosphate
  • 1,6-DI-O-PHOSPHONO-D-MANNITOL
  • N-(4-CHLOROPHENYL)-3-(PHOSPHONOOXY)NAPHTHALENE-2-CARBOXAMIDE

Page 21 out of 266 pages